Nephrology unit, Internal Medicine Department, Mansoura New General Hospital, Mansoura University, Mansoura, Egypt.
Rheumatology & Immunology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, El Gomhouria St, Mansoura, Dakahlia Governorate, 35511, Egypt.
BMC Musculoskelet Disord. 2022 Jun 23;23(1):606. doi: 10.1186/s12891-022-05512-5.
There is no much information about the entheseal involvement among hemodialysis (HD) patients. The aim of this study was to assess the frequency and distribution of ultrasonographic (US) entheseal alterations in HD patients and to evaluate the association between US abnormalities and both clinical and laboratory data.
This study was conducted on 41 HD patients and 23 sex- and age- matched controls. All participants were evaluated clinically for any signs of enthesopathy. Six entheses sites were scanned bilaterally using grey scale (GS) and power Doppler (PD) US and were scored using Madrid Sonography Enthesitis Index (MASEI) scoring system.
In HD patients, at least one clinical sign suggestive of enthesopathy was found in 69 (14%) of 492 entheses. HD patients had statistically significant higher scores of structural tendon abnormalities (p < 0.001), enthesis thickening (p < 0.001), bone erosions (p < 0.001) and calcification (p = 0.037) than the healthy controls. Total MASEI score was higher in HD patients than healthy controls (median;18 vs 8, p < 0.001), also, MASEI-inflammatory (median;11 vs 3, p < 0.001) and damage scores (median;6 vs 0, p < 0.001). There was a statistically significant positive association between total MASEI score and both age (p = 0.032) and duration of HD (p = 0.037). Duration of HD was predictive for both MASEI-damage component (p = 0.004) and total MASEI score (p = 0.014).
There is a high prevalence of subclinical enthesopathy in HD patients. The entheseal US alterations is much higher in HD patients than in healthy subjects. The duration of HD is the significant predictor of enthesopathy in HD patients.
关于血液透析(HD)患者的肌腱附着处受累情况,信息并不多。本研究旨在评估 HD 患者超声(US)肌腱附着处改变的频率和分布,并评估 US 异常与临床和实验室数据之间的关系。
本研究纳入了 41 名 HD 患者和 23 名性别和年龄匹配的对照组。所有参与者均进行了临床评估,以发现任何肌腱病的迹象。使用灰阶(GS)和能量多普勒(PD)US 双侧扫描 6 个肌腱附着处,并使用马德里超声肌腱附着病指数(MASEI)评分系统进行评分。
在 HD 患者中,492 个肌腱附着处中有 69 个(14%)至少有一个提示肌腱病的临床征象。HD 患者的结构肌腱异常评分(p<0.001)、肌腱附着处增厚(p<0.001)、骨侵蚀(p<0.001)和钙化(p=0.037)均显著高于健康对照组。HD 患者的总 MASEI 评分高于健康对照组(中位数;18 对 8,p<0.001),MASEI-炎症(中位数;11 对 3,p<0.001)和损伤评分(中位数;6 对 0,p<0.001)也更高。总 MASEI 评分与年龄(p=0.032)和 HD 持续时间(p=0.037)呈正相关。HD 持续时间是 MASEI-损伤成分(p=0.004)和总 MASEI 评分(p=0.014)的显著预测因素。
HD 患者存在较高的亚临床肌腱病患病率。HD 患者的肌腱附着处 US 改变明显高于健康受试者。HD 持续时间是 HD 患者肌腱病的重要预测因素。